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examination revealed a hyperemic mass obstructing the left nasal passage. The lesion’s sur-
face was smooth. The findings of imaging studies were consistent with a benign tumor despite
the erosion and perforation of the septum. The lesion originated from the middle concha and
was attached to it with a thin stalk. It was removed easily by endoscopic resection. Histopa-
thology revealed significant infiltration of mononuclear inflammatory cells, mostly lympho-
cytes and histiocytes, into the edematous subepithelial connective tissue. High-power
magnification showed numerous Leishmania amastigotes in the cytoplasm of the histiocytes.
A polymerase chain reaction experiment for Leishmania also confirmed the morphological
diagnosis. No relapse was observed in the 12 months after surgery and the patient was doing
well.
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unremarkable. Serological tests, namely, Hepatitis B sur-Leishmaniasis is a protozoal disease that is encountered in
many countries and is caused by parasites belonging to the
genus Leishmania. The prevalence of leishmaniasis has
been estimated to be 12 million cases worldwide, and
1e1.5 million new cases are being reported each year.1
Leishmania parasites, the causative agents of the disease,
are transmitted through the bites of the flies that are
known as Phlebotomus spp. in the Old World and as Lut-
zomyia spp. in the New World.2 In humans, leishmaniasis
occurs in three major clinical forms: cutaneous leishmani-
asis (CL), mucosal leishmaniasis (ML), and visceral leish-
maniasis.3 Nearly 90% of cases of visceral leishmaniasis are
reported from the Indian subcontinent and Sudan.4
Although CL is especially frequent in the Mediterranean
countries, including Turkey, ML is more frequent in South
America.5,6 Herein, we present an interesting case of ML,
which caused airway passage obliteration and nasal septum
perforation, mimicking a neoplastic process.Case report
A 79-year-old male who had been suffering from nasal
congestion was referred to our institution, Gulhane Military
Medical Academy and School of Medicine, and evaluated in
the outpatient service center of the ENT department. The
physical examination was otherwise normal, except for a
mass lesion in the left nasal passage. An endoscopic ex-
amination was performed; the results demonstrated the
lesion as a smooth-surfaced, hyperemic mass, filling the
entire left nasal passage and even causing erosion as well as
perforation in the posterior half of the nasal septum
(Fig. 1). A complete blood count, routine biochemical tests,
erythrocyte sedimentation rate, and protein electropho-
resis were performed, the results of all of which wereFigure 1. Endoscopic view of a hyperemic mass completely
filling the left nasal passage and perforating the septum
(arrows).normal. Chest X-ray and abdominal ultrasonography were
face antigen (HBsAg), Hepatitis C antibody (Anti-HCV), and
Human immunodeficiency virus antibody (Anti-HIV), were
all negative. A paranasal sinus computed tomography was
carried out in order to elucidate the characteristics of the
mass further. It confirmed that the mass lesion was filling
the left-side airway completely. Perforation of the septum
was also demonstrated clearly on the computed tomogra-
phy scan. At the perforation site, the lesion was pene-
trating the septum and extending to the right nasal passage
(Fig. 2).
The tumoral mass was attached to the left middle
concha with a thin stalk and was removed easily by endo-
scopic resection. No remnant of the lesion was found after
surgical removal (Fig. 3).
The histopathological examination, however, surpris-
ingly revealed that the lesion was inflammatory in nature,
characterized by heavy infiltration of mononuclear cells
such as lymphocytes and numerous histiocytes. Giemsa
stain highlighted innumerable LeishmaneDonovan bodies
within the histiocyte cytoplasm (Fig. 4).
Using a generic primer pair LGITSF2/LGITR2 which was
based on the sequences of the rRNA internal transcribed
spacer 2 (ITS2) region of multiple Leishmania species, as
previously described,7 were detected Leishmania species
in the nasal lesion (Fig. 5). A SYBR green-based real-time
polymerase chain reaction (PCR) assay under development
was used for categorization of the Leishmania spp. into
six different groups (unpublished data). Using this SYBR
green assay, the DNA sample extracted from the nasal
tissue was found to be positive for Leishmania donovani
complex.Discussion
In the Mediterranean basin where Turkey is located and in
the rest of the Middle East, CL is endemic. While CL is most
commonly seen in the south-eastern Anatolian region, some
sporadic cases are also being reported from other regions.6
Between 1991 and 2003, a total of about 26,000 CL cases,
most of them being from the province of Sanliurfa, was
reported.8 Studies have shown that the most commonly
seen subspecies is Leishmania tropica. The other subtypes,
such as Leishmania infantum, have rarely been reported.9
The mucosal manifestation (ML), although well known in
the New World, has occasionally been reported in the Old
World. While in the New World ML cases, the nose is the
most frequently affected area, other locations such as
buccal, pharyngeal, or laryngeal regions have been
described to be affected predominantly in the Mediterra-
nean ML cases. Mucosal involvement probably results from
a hematogenous or lymphatic spread from cutaneous
lesions.1,10
The present case was a 70-year-old man; his physical
examination and laboratory investigations revealed no
other pathology than the nasal mass. The patient was
regarded immunocompetent, and no skin lesions of leish-
maniasis were detected. The clinical history of patient was
unremarkable about any similar experience in the head and
neck region. Owing to the lack of a history of any pre-
Figure 2. Computed tomography sections, (A) coronal and (B) axial, demonstrating a mass lesion consistent with a neoplastic
growth completely filling the left nasal passage, perforating the septum, and even extending to the right nasal passage (arrows).
606 H.C. Gul et al.existing lesions, we considered the possibility of sand fly
bites that might have implanted the causative agents in the
patient’s nose. Previous reports in the literature regarding
intranasal ML cases demonstrated a similar lack of any
previous history of skin lesions, leading to conclusions
analogous to ours.11
The diagnosis of ML, as being routine in CL, is based on
the biopsy or culture and/or PCR of the materials taken
from the affected region. The sensitivity of culture and PCR
for Leishmania has been reported to be in the range of
42e46% and 80e98%, respectively.12 Fewer parasites were
observed in ML cases than in CL cases; hence, establishing a
definite diagnosis is not always easy and possible. Pirmez
et al13 have reported that only 17% of ML cases are smear
positive, while 71% are PCR positive. In our case, we could
both manage to observe LeishmaneDonovan bodies in tis-
sue sections and obtain a positive result in PCR for the
Leishmania donovani complex. The samples were not
cultured due to technical difficulties and involvement of a
time-consuming procedure.Figure 3. Appearance of the nasal cavity after the excision
of the mass (endonasal endoscopic examination).In ML, septal perforation and facial deformities may
occur due to erosion in the underlying nasal bone and
cartilages. In the known literature, nasal septum perfora-
tion was most commonly found to be associated with
Leishmania braziliensis. However, our patient had the L.
donovani complex.4,11
In a study conducted by Camargo et al,14 26 patients
having leishmaniasis with nasal involvement were evalu-
ated by computed tomography. The most consistent finding
among these patients was mucosal thickening. The authors,
with support from this finding, have concluded that the
lesions in these patients are not limited to the nasal mucosa
but extend to the paranasal sinuses.
Pentavalent antimonial compounds are the drug of
choice in the treatment of ML the. Alternatively, pentam-
idine isethionate and amphotericin B can also be used. The
present case was operated by an otorhinolaryngologist,
taking into account the possibility of a neoplasm. The mass-
like lesion was excised with clean surgical margins.Figure 4. Giemsa-stained light microscopic image of the
lesion revealing numerous Leishmania bodies in the cytoplasm
of the histiocytes (inside the green circle) (Giemsa stain;
magnification 100).
Figure 5. Agarose gel electrophoresis showing PCR ampli-
cons (w420 bp) produced with generic primers LGITSF2/
LGITSR2; DNA was extracted from the nasal tissue. Lane 1,
negative control; lane 2, L. donovani positive control; lanes 3
and lane 4, DNA from the nasal tissue; lane S, 100-bp ladder-
size standards.
Intranasal leishmaniasis 607Therefore, we thought that no medical treatment would be
required. A relatively long follow-up period without any
relapse supports our decision.
In conclusion, localized nasal ML is not frequently
encountered in our geographical region. However, this
should be kept in mind as a possible differential diagnosis of
nasal masses and must be treated accordingly.
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